Showing results (191-200 of 227) with videos related to
Sort By:
Pageof 23
Therapeutic Advances in Neurological Disorders|November 6, 2014
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysisKathrin S Utz, Jana Hoog, Andreas Wentrup, et al.Plos One|July 12, 2021
Influence of transfusions, hemodialysis and extracorporeal life support on hyperferritinemia in critically ill patientsCornelia Knaak, Friederike S Schuster, Peter Nyvlt, et al.Research in Developmental Disabilities|March 18, 2025
The Dice Trails Test: A modified Trail Making Test for children and adults with Down SyndromeKatja Sandkühler, Elisabeth Wlasich, Hannah Stadler, et al.BMC Pulmonary Medicine|February 28, 2014
Quality of life is associated with physical activity and fitness in cystic fibrosisHelge Hebestreit, Kerstin Schmid, Stephanie Kieser, et al.AAPS Pharmscitech|January 31, 2020
Physical Barrier Type Abuse-Deterrent Formulations: Mechanistic Understanding of Sintering-Induced Microstructural Changes in Polyethylene Oxide Placebo TabletsHeather J Boyce, Vivek S Dave, Myke Scoggins, et al.BMJ Open|December 17, 2021
Predictive validity of A-level grades and teacher-predicted grades in UK medical school applicants: a retrospective analysis of administrative data in a time of COVID-19I C McManus, Katherine Woolf, David Harrison, et al.Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|June 27, 2017
Visual feedback explains why propointing is better than antipointing in spatial neglectKathrin S Utz, Constanze Hesse, Annika Hintz, et al.Acta Crystallographica. Section E, Crystallographic Communications|May 3, 2021
Maleate salts of bedaquilineMatthias Zeller, Susan Bogdanowich-Knipp, Pamela Smith, et al.Journal of Clinical Medicine|January 8, 2023
Differential Diagnosis of Hyperferritinemia in Critically Ill PatientsFriederike S Schuster, Peter Nyvlt, Patrick Heeren, et al.Journal of Cancer Research and Clinical Oncology|October 2, 2015
Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantationChristian Pfrepper, Anne Klink, Gerhard Behre, et al.Pageof 23